Method and Formulation for Improving Roflumilast Skin Penetration Lag Time | Patent Publication Number 20230346690
US 20230346690 A1Publication DateNov 2, 2023
Original AssigneeArcutis Biotherapeutics Inc.
Current AssigneeArcutis Biotherapeutics Inc.
Inventor/ApplicantsDavid W. OSBORNE
Empower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.